NR3C1 and schizophrenia: Taking into account these research gaps, we aimed to investigate the levels of NR3C1 methylation in acutely relapsed schizophrenia patients (SCZ-AR), FEP patients, individuals at familial high risk of psychosis (FHR-P), and healthy controls.